Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Monika Engel
Observed name:
Engel, Monika
Institutions:
Universitätsklinikum Tübingen,
University of Tübingen
Observed institutions:
German Cancer Research Center,
Johannes Gutenberg University Mainz,
Universitätsklinikum Tübingen,
Deutsches Konsortium für Translationale Krebsforschung,
University of Tübingen
ORCID:
0009-0006-2686-5960
Observed ORCID:
0009-0006-2686-5960
OpenAlex ID:
A5001434619
Synthesis, structure and properties of liquid crystalline polymers
1985
·
Monika Engel
, Bernd Hisgen
, et al.
·
Pure and Applied Chemistry
·
158
PDF
An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers
2023
·
Latifa Zekri
, Martina Lutz
, et al.
·
Molecular Therapy
·
58
B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma
2022
·
Ilona Hagelstein
, Monika Engel
, et al.
·
Frontiers in Immunology
·
20
Abstract 2865: CC-3, an IgG-based B7-H3xCD3 bispecific antibody for targeting of gastrointestinal cancers
2022
·
Latifa Zekri
, Martina S. Lutz
, et al.
·
Cancer Research
·
2
Abstract 3797: Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of CD3-bispecifics and mitigate T cell exhaustion
2025
·
Latifa Zekri
, Nisha Prakash
, et al.
·
Cancer Research
·
1
Bivalent bispecific CD28-antibodies reinforce T-cell responsiveness and revert anergy/quiescence in patients treated with bispecific CD3-antibodies
2026
·
Latifa Zekri
, Natalie Köhler
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
1298 Two targets, two signals: combinatorial cancer therapy with bispecific antibodies directed to CD3 and CD28 improves specificity and prevents T-cell exhaustion
2024
·
Ilona Hagelstein
, Latifa Zekri
, et al.
·
Journal for ImmunoTherapy of Cancer
Show more works
View as search
Works count:
8
Citation count:
239
H-index:
3
I10-index:
3
Year
Topic
Type